Research ArticleCORONAVIRUS

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality

See allHide authors and affiliations

Science Advances  01 Jan 2021:
Vol. 7, no. 1, eabe4724
DOI: 10.1126/sciadv.abe4724
PDF Container

Stay Connected to Science Advances

Navigate This Article